Targeted gene therapy for neuropathic pain based on viral vectors
Neuropathic pain(NP)is defined as pain resulting from lesions or diseases of the somatosensory system,significantly impacting patients'physiological and psychological well-being.However,current treatment effect is often not ideal.As an emerging treatment strategy,gene therapy has been showed in various studies to alleviate NP via virus vector-mediated approaches.Therefore,based on the pathological and physiological mechanisms of NP,this article focuses on discussing gene therapy based on viral vectors to alleviate NP and summarizes gene therapy targeting different targets.This provides useful references and treatment insights for future research directions in the field of NP.